These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23101994)

  • 1. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
    Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
    Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.
    Naiken SP; Toso C; Rubbia-Brandt L; Thomopoulos T; Roth A; Mentha G; Morel P; Gervaz P
    BMC Surg; 2014 Jan; 14():4. PubMed ID: 24438090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab].
    Nakano M; Kameyama H; Shimada Y; Hashimoto Y; Hosoi M; Nakano M; Nogami H; Hanyu T; Takizawa K; Ishikawa T; Sakata J; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Wakai T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1785-7. PubMed ID: 25731329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Ascending Colon Cancer with Synchronous Liver Metastases and Peritoneal Dissemination].
    Mito M; Kameyama H; Shimada Y; Yamada S; Hotta S; Hirose Y; Yagi R; Tajima Y; Nakano M; Okamura T; Nakano M; Ichikawa H; Nagahashi M; Sakata J; Wakai T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1126-1128. PubMed ID: 29394555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Neuroendocrine Carcinoma of the Ascending Colon That Responded Completely to Chemotherapy].
    Satake M; Yoshimatsu K; Ito Y; Imaizumi R; Sano M; Kodera A; Miyano Y; Koike T; Yamada Y; Okayama S; Yokomizo H; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1513-1515. PubMed ID: 30382062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX.
    Leite D; Kater FR
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S1-7. PubMed ID: 21768791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.
    Toyama Y; Ushigome T; Watanabe K; Kitamura H; Onda S; Saito R; Yoshida S; Kawahara H; Yanagisawa S; Yanaga K
    World J Surg Oncol; 2012 Jun; 10():129. PubMed ID: 22747970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
    Ojima E; Nakano T; Kanamoto A; Sasaki S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver resection after FOLFOX with bevacizumab.
    Mickle M; Mulcahy MF
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy].
    Yamanashi T; Nishi T; Yamamoto T; Toriumi F; Koshida Y; Mukai K; Shimoyama Y
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):107-12. PubMed ID: 24423963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
    Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
    Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
    World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Synchronous Multiple Liver Metastases from Ascending Colon Cancer Showing Pathological Complete Response to CapeOX Treatment].
    Okugawa K; Ioka E; Ishikawa T; Takemoto M; Osaka M; Kadotani Y; Nakano K; Akioka K; Osaka Y; Tsuchiya K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1913-1915. PubMed ID: 29394818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of long-term survival due to combined modality therapy for liver metastasis of colon cancer].
    Hasegawa H; Hashimoto T; Nakamura T; Kitagawa M; Kudo K; Shoji F; Kabashima A; Teramoto S; Kitamura M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2234-6. PubMed ID: 23268034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
    de Gramont A; Van Cutsem E; Schmoll HJ; Tabernero J; Clarke S; Moore MJ; Cunningham D; Cartwright TH; Hecht JR; Rivera F; Im SA; Bodoky G; Salazar R; Maindrault-Goebel F; Shacham-Shmueli E; Bajetta E; Makrutzki M; Shang A; André T; Hoff PM
    Lancet Oncol; 2012 Dec; 13(12):1225-33. PubMed ID: 23168362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
    Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
    World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative chemotherapy with modified FOLFOX + panitumumab for the treatment of descending colon cancer with multiple liver metastases - a case study].
    Yagi Y; Yamazaki T; Iwaya A; Manabe S
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):109-12. PubMed ID: 25596691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effective chemotherapy with bevacizumab/FOLFOX4 for neuroendocrine carcinoma of the ascending colon - a case study].
    Tanabe H; Takase T; Morimoto D; Tanaka Y; Shibata A; Yaguchi T
    Gan To Kagaku Ryoho; 2014 May; 41(5):661-4. PubMed ID: 24917018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A recurrence after surgery for colon cancer with metastases of the liver and periaortic lymph nodes, with CR achieved by using bevacizumab+mFOLFOX6].
    Matsukawa S; Shiratori T; Kugimiya M; Matsuo S; Kaji S; Aoyama Y
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1389-91. PubMed ID: 20647734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver damage detected after a hepatectomy for liver metastasis after 12 courses of mFOLFOX6 therapy as an adjuvant chemotherapy for colorectal cancer].
    Makino S; Murata K; Murakami M; Wada Y; Kato R; Nishigaki T; Owada Y; Okada K; Yanagisawa T; Okamura S; Ebisui C; Yokouchi H; Kinuta M; Nakagomi N; Tamai M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2222-4. PubMed ID: 23268030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.